Packaging Size	25 KGS
Usage	Laboratory, Commerical
Physical State	Granules, Powder
Packaging Type	Export Worthy Packing of 25 Kilos or as per Our Customer Requirements
Grade Standard	Analytical Grade

Indications and Usage for Tamsulosin

Tamsulosin hydrochloride capsules, USP are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH)
Tamsulosin hydrochloride capsules, USP are not indicated for the treatment of hypertension.

Tamsulosin Dosage and Administration

Tamsulosin hydrochloride capsule USP, 0.4 mg once daily is recommended as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately one-half hour following the same meal each day. Tamsulosin hydrochloride capsules, USP should not be crushed, chewed or opened.

Usage	Industrial, Commerical
Physical State	Granules, PELLETS
Packaging Size	50 KGS
Packaging Type	Export Worthy Packing of 25 Kilos or as per Our Customer Requirements
Grade Standard	Technical Grade, Bio-Tech Grade

ASPIRE HEALTHCARE is a young and dynamic drug delivery systems (DDS) company in India that provides a range of effective solutions to optimize the delivery of pharmaceutical products. Our manufacturing plant is approved for GMP Compliance by the WHO and the European Union; ASPIRE HEALTHCARE is equipped to undertake formulation development projects on oral NDDS. Our encapsulation covers micro pellets & this expertise is being extended to the development of nano-particles. Our Therapeutic segment ranges from • Gastro - Protection and Gastro-Retention Products • Anti - Infective Products • Anti - Pain or Pain Management Products • Anti Obesity Products • Taste Masking Products • Immune Suppressants

Dosage Form (If Applicable)	Capsules, POWDER
Usage	Commercial, Personal
Product Type	on
Packaging Size	Export Worthy Packing of 25 Kilos or as per Our Customer Requirements
Dose	1

Omeprazole Pellets

Grade Standard	Medicine Grade
Type Of API	Innovative
Manufacturing Process	Chemical Synthesis
Therapeutic Area	Cardiovascular Diseases
API Form	Powder

Sevelamer hydrochloride & Carbonate CAS Number : 152751-57-0 Synonyms: 2-(chloromethyl)oxirane; prop-2-en-1-amine; hydrochloride; 2-Propen-1-amine,hydrochloride,polymer with (chloromethyl)oxirane; RenaGel (TN); Sevelamer hydrochloride (JAN/USAN);Sevelamer HCL; RenaGel; Molecular Formula: (C3H7N)m. (C3H5ClO)n.(HCl)x Assay: 99% min An Improved process for preparation of Sevelamer hydrochloride having phosphate binding capacity of 4.7 to 6.4 mmol/g comprising the steps of: (a) dissolving polyallylamine hydrochloride in water to obtain an aqueous solution; (b) partially neutralizing the aqueous solution of polyallylamine hydrochloride with 65 to 70 mole % of alkali with respect to polyallylamine hydrochloride; (c) charging dispersing agent to hydrocarbon solvent to obtain solution; (d) mixing partially neutralized aqueous polyallylamine hydrochloride solution with the solution obtained in step (c); (e) stirring the obtained reaction mixture at speed of about 40 to about 250 revolutions per minute to get fine dispersion of aqueous phase in organic phase; (f) heating the suspension obtained in step (e) at elevated temperature; (g) charging 5 to 12 % by weight of epichlorohydrin with respect to polyallylamine hydrochloride to the suspension of step (f) maintaining elevated temperature till cross linking is complete; (h) cooling the reaction mixture at temperature of 25 to 35° C. and isolating the compound by washing the obtained cake with water and (i) drying the wet cake in a Fluidized Bed Dryer at temperature of about 25° C. to about 90° C. to get Sevelamer hydrochloride with phosphate binding capacity of 4.7 to 6.4 mmol/g. Detailed offer Description Sevelamer Hydrochloride is a polymeric amine that binds phosphate and is meant for oral administration. Sevelamer hydrochloride is poly(allylamine hydrochloride) crosslinked with epichlorohydrin in which forty percent of the amines are protonated. It is known chemically as poly (allylamine-co-N,N'-diallyl- 1,3-diamino-2-hydroxypropane) hydrochloride. Sevelamer hydrochloride is hydrophilic, but insoluble in water. Object Of The Invention The main object of the present invention is to provide industrial process for preparation of Sevelamer hydrochloride having PA in the range of about 4.7 mmol/g to about 6.4 mmol/g and chloride content in the range of about 3.74 to about 5.60 meq/g. Another object of the invention is to provide pharmaceutical compositions comprising a therapeutically effective amount of Sevelamer hydrochloride along with suitable pharmaceutically acceptable excipients. Another object of the invention is to provide a novel process for preparation of Sevelamer hydrochloride compositions comprising high shear non-aqueous granulation. Another object of the invention is to provide improved and simplified process for preparation of Sevelamer hydrochloride which will eliminate the use of acetonitrile and the risk of gelling also avoid use of IPA for removing water. Another object of the invention is to provide Sevelamer hydrochloride which will meet the stringent ICH (International Committee of Harmonisation) requirements. Yet another object of the invention is to provide process which yields Sevelamer hydrochloride having consistency in degree of cross linking and avoids the need of specialized equipments for the manufacture of the said product and thereby reducing the manufacturing cost. Still another object of the invention is to provide compositions for the control of serum phosphorus in patients with Chronic Kidney Disease (CKD) on hemodialysis.

Purity (in %)	99
Physical State	Powder, solid
Grade Standard	Medicine Grade, Industrial Grade
Release Type	Quick
API Form	POWDER
Purity (%)	99%
Assay (%)	99%
Packaging Type	Export Worthy
Packaging Size	25 Kg
Usage	Commerical
Assay	99%
Purity	99%
CAS Number	161796-78-7

RUG DESCRIPTION

The active ingredient in (esomeprazole sodium) for Injection is (S)-5-methoxy-2[[(4-methoxy-3,5dimethyl-2-pyridinyl)-methyl]sulfinyl]-1 H-benzimidazole sodium, a proton pump inhibitor that inhibits gastric acid secretion. Esomeprazole is the S-isomer of omeprazole, which is a mixture of the S- and R- isomers. Its empirical formula is C₁₇H₁₈N₃O₃SNa with molecular weight of 367.4 g/mol (sodium salt) and 345.4 g/mol (parent compound). Esomeprazole sodium is very soluble in water and freely soluble in ethanol (95%). The structural formula is

 

 

esomeprazole sodium for Injection is supplied as a sterile, freeze-dried, white to off-white, porous cake or powder in a 5 mL vial, intended for intravenous administration after reconstitution with 0.9% Sodium Chloride Injection, USP; Lactated Ringer''s Injection, USP or 5%DextroseInjection, USP. esomeprazole sodium. for Injection contains esomeprazole sodium 21.3 mg or 42.5 mg equivalent to esomeprazole 20 mg or 40 mg, edetate disodium 1.5 mg and sodium hydroxide q.s. for pH adjustment. The pH of reconstituted solution ofesomeprazole sodium. for Injection depends on the reconstitution volume and is in the pH range of 9 to 11. The stability of esomeprazole sodium in aqueous solution is strongly pH dependent. The rate of degradation increases with decreasing pH.

Additional Information:

• Pay Mode Terms: L/C (Letter of Credit),T/T (Bank Transfer)
• Port of Dispatch: NHAVA SHEVA
• Production Capacity: 10000 KGS
• Delivery Time: 2-3 DAYS